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Here we describe the successful synthesis of cyclic ADP-4-thioribose (cADPtR, 3), designed as a stable mimic of
cyclic ADP-ribose (cADPR, 1), a Ca2+-mobilizing second messenger, in which the key N1--thioribosyladenosine
structure was stereoselectively constructed by condensation between the imidazole nucleoside derivative 8 and
the 4-thioribosylamine 7 via equilibrium in 7 between the -anomer (7) and the -anomer (7) during the reaction
course. cADPtR is, unlike cADPR, chemically and biologically stable, while it effectively mobilizes intracellular
Ca2+ like cADPR in various biological systems, such as sea urchin homogenate, NG108-15 neuronal cells, and
Jurkat T-lymphocytes. Thus, cADPtR is a stable equivalent of cADPR, which can be useful as a biological tool for
investigating cADPR-mediated Ca2+-mobilizing pathways.
Keywords: Cyclic ADP-Ribose, cADPR, Second Messenger, Ca2+-Release.
INTRODUCTION
Cyclic ADP-ribose (cADPR, 1, Fig. 1), a metabolite of
NAD+ (nicotinamide adenine dinucleotide), was originally
isolated from sea urchin by Lee and co-workers (Clap-
per et al., 1987). cADPR mobilizes intracellular Ca2+
in various mammalian cells, such as, pancreatic -cells,
smooth muscle, cardiac muscle, T-lymphocytes, and cere-
bellar neurons, and therefore, cADPR is now recognized
as a general mediator of intracellular Ca2+ signaling
(Galione, 1993; Lee, 1997; Galione et al., 1998; Guse,
1999; Higashida et al., 2001; Lee, 2002; Guse, 2004;
∗Author to whom correspondence should be addressed.
E-mail: shu@pharm.hokudai.ac.jp
Zhang and Li, 2006; Jin et al., 2007; Venturi et al., 2010;
Lee, 2012).
Analogs of cADPR have been extensively designed and
synthesized, since they are potentially useful for investi-
gating the mechanism of cADPR-mediated Ca2+ release
(Walseth and Lee, 1993; Lee et al., 1993; Zhang and Sih,
1995; Ashamu et al., 1995; Wagner et al., 2003, 2005;
Moreau et al., 2006, 2012; Galeone et al., 2002; Huang
et al., 2002; Gu et al., 2004; Xu et al., 2006; Swarbrick
and Potter, 2012; Yu et al., 2012; Shuto et al., 1998;
Fukuoka et al., 2000; Shuto et al., 2001; Guse et al.,
2002; Shuto et al., 2003; Kudoh et al., 2005; Hashii et al.,
2005; Kudoh et al., 2008; Zhang et al., 1999; Shuto and
Matsuda, 2004; Guse, 2004; Potter and Walseth, 2004).
cADPR analogs are also expected to be lead structures for
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Figure 1. cADPR (1), cADPcR (2), cADPtR (3) and cIDPR (4).
the development of potential drug candidates, due to the
important physiological roles of cADPR (Galione, 1993;
Lee, 1997; Galione 1998; Guse, 1999; Higashida et al.,
2001; Lee, 2002; Guse, 2004; Zhang, 2006; Jin et al.,
2007; Venturi et al., 2010; L e, 2012). cADPR a alogs
have been synthesized predominantly by enzymatic and
chemo-enzymatic methods using ADP-ribosyl cyclase-
catalyzed cyclization under mild conditions (Walseth and
Lee, 1993; Lee et al. 1993; Zhang and Sih, 1995; Ashamu
et al., 1995; Wagner et al., 2003, 2005; Moreau et al.,
2006, 2012). The analogs obtained by these methods, how-
ever, are limited due to the substrate-specificity of the
ADP-ribosyl cyclase (Zhang et al., 1999; Shuto and Mat-
suda, 2004; Guse, 2004; Potter and Walseth, 2004).
In recent years, methods for the chemical synthesis
of cADPR analogs have been studied to develop useful
cADPR analogs (Galeone et al., 2002; Huang et al., 2002;
Gu et al., 2004; Xu et al., 2006; Swarbrick et al., 2012;
Yu et al., 2012; Shuto et al., 1998; Fukuoka et al., 2000;
Shuto et al., 2001; Guse et al., 2002; Shuto et al., 2003;
Kudoh et al., 2005; Hashii et al., 2005; Kudoh et al.,
2008; Zhang et al., 1999; Shuto et al., 2004; Gusu et al.,
2004; Potter et al., 2004). Construction of the characteris-
tic pyrophosphate-containing 18-membered ring structure
is the key to the synthesis of cADPR and its analogs,
and we have developed an efficient method for forming
the ring using S-phenyl phosphorothioate-type substrates,
which can be effectively activated by Ag+ or I2 (Fukuoka
et al., 2000; Shuto et al., 2001).
cADPR is readily hydrolyzed at the unstable N1-ribosyl
linkage to produce ADP-ribose (ADPR), even in neutral
aqueous solution (Lee and Aarhus, 1993). This is due to
the fact that cADPR is in a zwitterionic form positively
charged around the N1-C6-N6 moiety (pKa = 83), making
the molecule unstable, where the charged adenine moiety
attached to the anomeric carbon of the N1-linked ribose is
able to be an efficient leaving group. Under physiological
conditions, cADPR is also hydrolyzed at the same N1-
ribosyl linkage by cADPR hydrolase to give the inactive
ADPR (Lee and Aarhus, 1993).
We previously designed and synthesized cyclic ADP-
carbocyclic-ribose (cADPcR, 2) as a stable mimic of
cADPR, in which the oxygen atom in the N1-ribose ring of
cADPR is replaced by a methylene group. cADPcR is both
chemically and biologically stable, and effectively mobi-
lizes intracellular Ca2+ in sea urchin eggs (Shuto et al.,
2001). Although cADPcR is more potent than cADPR in
neuronal cells (Hashii et al., 2005), it is almost inactive
in T cells, whereas natural cADPR effectively mobilizes
Ca2 in both neuronal cells and T cells (Guse et al., 2002;
Kudoh et al., 2005).
Although intensive studies of the signaling pathway that
uses cADPR are still needed because of its biological
importance, the biological as well as chemical instabil-
ity of cADPR limits further studies of its physiologi-
cal role. Therefore, stable analogs of cADPR exhibiting
Ca2+-mobilizing activity in various cells including T cells
are required. Thus, we newly designed and synthesized
a 4-thioribose-containing analog of cADPR, i.e., cyclic
ADP-4-thioribose (cADPtR, 3), in which the N1-ribose of
cADPR is replaced by a 4-thioribose. Evaluations in sev-
eral biological systems revealed that cADPtR is a stable
equivalent of cADPR, which mobilizes intracellular Ca2+
not only in sea urchin eggs and neuronal cells, but also in
T cells. Here we report the detailed results of these studies
on cADPtR.
RESULTS AND DISCUSSION
Design of cADPtR
cADPR is in an equilibrium between the N6-protonated
amino-form and the N6-deprotonated imino-form, as
shown in Figure 2 (Lee et al., 1989; Kim et al., 1993;
Lee et al., 1994; Gu and Sih, 1994; Wada et al., 2005;
Wada and Pope, 2001; Graham et al., 2004). One differ-
ence between cADPR and cADPcR is their pKa values
for protonation at the N6-position. The pKa of cADPcR
(8.9) (Guse et al., 2002) is somewhat higher than that of
cADPR (8.3) (Kim et al., 1994), which might affect its
interaction with target proteins. Under physiological con-
ditions, cADPR is in a mixture of the protonated amino
form and the deprotonated imino form, where most of
cADPcR should be present in the amino-form due to its
relatively higher pKa. If cADPR binds to the target pro-
tein in T cells in the imino-form, activity of cADPcR
would be decreased. In recent years, cADPR analogs with
a hypoxanthine base instead of an adenine base, such as
cyclic IDP-ribose (cIDPR, 4, Fig. 1), were synthesized,
36 MESSENGER 3, 35–51, 2014
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Figure 2. Equilibrium between the N6-protonated amino-form
and the N6-deprotonated imino-form in cADPR and cADPcR.
and these hypoxanthine-type analogs also mobilized Ca2+
in T cells, while they were almost inactive in other bio-
logical sytems (Moreau et al., 2006; Huang et al., 2002;
Gu et al., 2004; Xu et al., 2006). These findings support
the idea of an active imino-form of cADPR in T cells,
because the C6 O6 moiety might work as a bioisostere
of the plane C6 N6 moiety of the imino-form of cADPR,
due to their analogous unsaturated -electronic structural
features.
Another difference between cADPR and cADPcR might
be their three-dimensional structures. In nucleosides, con-
formation around the glycoside linkage is one of the deter-
minants of their biological activities, and they generally
prefer a conformation that avoids steric repulsion between
the nucleobase and sugar moieties (Saenger, 1983). There-
fore, in cADPR and its analogs, the most stable conforma-
tion can be the one with minimal steric repulsion between
the adenine moiety and both of the N1- and N9-ribose
moieties. It should be noted that, in cADPcR, the hydro-
gens on the tetrahedral sp3-C6′′-, particularly the H6′′-,
which is absent in cADPR, are rather sterically repulsive
to the adenine H2 (Fig. 3). Accordingly, the stable confor-
mation of cADPcR would differ from that of cADPR due
to the steric effects (Kudoh et al., 2008).
Taking these considerations into account, we newly
designed cADPtR, a 4-thioribose analog of cADPR. 4′′-
Thionucleosides are recognized as useful bioisosteres of
the natural nucleosides, which are extensively used in stud-
ies of medicinal chemistry and chemicalbiology (Reist
et al., 1964; Bobek and Whistler, 1970; Dyson et al.,
1991; Bellon et al., 1993; Yoshimura et al., 1997; Naka
et al., 2000; Takahashi et al., 2009). The 4-thioribose in 4′′-
thionucleosides does not only effectively mimics the ribose
Figure 3. Possible steric repulsion between the H2 and the
H6′′.
of nucleosides, but also the N-4-thioriobyl linkage is more
stable than the corresponding N-ribosyl linkage against
both chemical and enzymatic hydrolysis (Elzagheid et al.,
1999; Toyohara et al., 2003). In addition, the pKa value of
cADPtR is expected to be similar to that of cADPR due
to the electron-withdrawing property of sulfur atom. This
type of pKa adjustment of biologically active compounds
by replacing a methylene with a sulfur has been reported
previously (Ganellin and Owen, 1977). Furthermore, the
conformation of cADPtR, particularly spatial positioning
of the N1-thioribose and adenine moieties, would be sim-
ilar to that of cADPR, because both sulfur and oxygen
have a similar sp3 configuration bearing two non-bonding
electron pairs. Thus, we expected that cADPtR might be
a stable cADPR equivalent that is active in various cells
including T cells.
Synthetic Plan
The retrosynthetic scheme for the target cADPtR (3) is
shown in Figure 4. For the synthesis of cADPtR, con-
struction of the 18-membered pyrophosphate structure is
an important step. The structure was likely to be con-
structed using the intramolecular condensation reaction
with an S-phenyl phosphorothioate-type substrate that we
developed (Fukuoka et al., 2000; Shuto et al., 2001),
which has been effectively used in the synthesis of a
variety of cADPR analogs (Galeone et al., 2002; Huang
et al., 2002; Gu et al., 2004; Xu et al., 2006; Swar-
brick et al., 2012; Yu et al., 2012). Thus, treatment of
the S-phenyl phosphorothioate-type substrates 5 having the
N1-4-thioribosyladenosine structure with AgNO3/MS3A
as a promoter (Fukuoka et al., 2000; Shuto et al., 2001)
would form the desired cyclization product, and sub-
sequent deprotection would furnish the target cADPtR.
The S-phenyl phosphorothioate-type substrates 5 would
be obtained from the N1--thioribosyl adenosine deriva-
tive 6, which we planned to construct by condensation
between the 4-thioribosylamine 7 and a known imidazole
nucleoside derivative 8 (Hutchinson et al., 1997) read-
ily prepared from inosine. The 4-thioribosylamine 7 was
expected to be prepared from the 1-deoxy-4-thioribose
derivative 9, obtained by a known method (Jeong et al.,
2006).
In this synthetic plan, we first had to achieve stere-
oselective construction of the N1--thioribosyladenosine
structure. Although no 4-thioribse derivatives having an
anomeric amino function such as 7 have been reported to
date, 4-thioribosylamine 7 is likely to be present as an
anomeric mixture, due to the electron-donating property
of the hemiaminal ether nitrogen attaching at the anomeric
position. We speculated that if the 4-thioribosylamine
derivative 7 is indeed in equilibrium between the -anomer
(7) and the -anomer (7), stereoselective construc-
tion of the N1--thioribosyladenosine structure might be
MESSENGER 3, 35–51, 2014 37
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Figure 4. Retrosynthetic analysis of the target cADPtR (3).
achieved. In the 4-thioribosylamine 7, the -face would be
rather sterically more hindered than the -face due to its
rigid 5,5-cis ring system. Thus, as shown in Figure 5, in
the condensation reaction, the -anomer 7 might prefer-
entially react with the imidazole nucleoside 8, while the
-anomer 7 might not react due to the steric hindrance
by the adjacent isopropylidene moiety. Thus, we expected
that, in the reaction course, the relatively less reactive -
anomer would not undergo the condensation, but rather
would be effectively converted into the more reactive -
anomer via the equilibrium to result in accumulation of
the desired -condensation product 6.
Synthesis
The 4-thioribosylamine 7 was prepared from the known
1-deoxy-4-thioribose derivative 9 (Jeong et al., 2006), as
shown in Scheme 1. While several procedures for synthe-
sizing 4-thioribose derivatives have been reported (Reist
et al., 1964; Bobek and Whistler, 1970; Dyson et al., 1991;
Bellon et al., 1993; Yoshimura et al., 1997; Naka et al.,
2000; Takahashi et al., 2009), we selected the procedure
recently developed by Jeong and co-workers (Jeong et al.,
2006), which is effective for large scale preparation of the
4-thio-1-deoxyribose derivative 9 having the desired 2,3-
O-isopropylidene protecting group. Oxidation of 9 with
Figure 5. Hypothesis for the stereoselective formation of the
desired -product 7 via the / equilibrium.
m-CPBA and subsequent heating of the resulting sulfoxide
product in Ac2O to initiate the Pummerer rearrangement
afforded the 1-acetoxy product 11 as an anomeric mixture
(/ = 1:5). When the anomeric mixture 11 was treated
with TMSN3 and SnCl4 in CH2Cl2, the -azide 12 was
obtained stereoselectively in high yield, probably due to
the steric demand of the reaction intermediate. Reduction
of the azido group of 12 by catalytic hydrogenation, fol-
lowed by removal of the O-acetyl group by heating it in
MeOH gave the 4-thioribosylamine 7, which appeared to
be an anomeric mixture (/= 1:2) as we expected.
We next investigated the key condensation between the
4-thioribosylanine 7 (/= 1:2) and the imidazole nucle-
side 8 under various conditions. Under basic reaction
conditions, i.e., K2CO3/MeOH which was previously used
to construct the N1-carbocyclic-ribosyladenine structures
(Shuto et al., 2001), the desired -condensation product
6b was actually obtained stereoselectively in 50% yield.
Under the conditions, however, the N6-(4-thioribosy) prod-
uct 13 via a Dimroth rearrangement was also obtained
in 28% yield. As a result, we found that when 7 was
treated with 8 (2.1 eq) in MeOH at room temperature
without any bases, the -product 6b was obtained in
61% yield concomitant with 5% of the -product 6a,
where the 4-thioribosylamine 7 was recovered in 17%
yield (Scheme 2). Thus, the desired -product 6b was
successfully obtained in 73% conversion yield from the
Scheme 1. Synthesis of 4-thioribosylamine 7.
38 MESSENGER 3, 35–51, 2014
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Scheme 2. Stereoselective synthesis of N1--thioribosyladeno-
sine derivative 6.
4-thioribosylamine (/ = 1:2) via the /-equilibrium,
as we hypothesized. In the reaction conditions, the N6-
thioribosyl product 13 (4%) was also obtained.
The N1-substituted structures of 6a and 6b was con-
firmed based on their HMBC spectra, in which corre-
lation between the H2 of the adenine and the C1′′ of
the 4-thioribose moiety was observed. The - and -
stereochemistries of 6a and 6b were confirmed by NOE
data (see Fig. 11).
Conversion of the N1--thioribosyl product 6b into
the S-phenyl phosphorothioate-type substrate 5 was
next investigated (Scheme 3). The 5′′-hydroxy group
of 6b was protected with a dimethoxytrity (DM r)
group, and then the 5′′-O-TBS group of the prod-
uct 14 was removed with TBAF to give 15. Treat-
ment of 15 with an S,S ′′-diphenylphosphorodithioate
Scheme 3. Investigation for synthesizing 5′-bis-S-(phenyl)phosphorothioate 17.
(PSS)/2,4,6-triisopropylbenzenesulfonyl chloride (TPSCl)/
pyridine system (Sekine et al., 1985; Sekine and Hata,
1993), followed by removal of the 5′′′′-O-DMTr group of
the product 16 with aqueous AcOH gave the 5′′-bis-S-
(phenyl)phosphorothioate 17.
We next examined phosphorylation of the 5′′-hydroxyl
of 17. However, treatment of 17 under the usual con-
ditions of Yoshikawa’s phosphorylation procedure with
POCl3/(EtO)3PO (Yoshikawa et al., 1969), which was
effective in the previous synthesis of cADPcR and its
analogs, gave none of the desired phosphorylation prod-
uct 18.
Difficulties in the phosphorylation of the 4-thioribose
moiety could be assumed to occur, at least partially,
because phosphorylation of the 5′′-primary hydroxyl of
4′-thioribnucleoside derivatives is rather difficult com-
pared to the cases with usual ribonucleosides (Hancox and
Walker, 1996; Alexandova et al., 1996). Walker and co-
workers reported that phosphorylation of 4′′-thiothymidine
by Yoshikawa’s procedure did not give the desired cor-
responding 5′′-O-phosphate product. They suggested that
elimination of the dichlorophosphate moiety would occur
in an intermediate A due to effective neighboring group
participation by the nucleophilic ring sulfur to result in
reproducing the starting material 4′′-thiothymidine, via a
thionium intermediate B and its subsequent hydrolysis, as
shown in Scheme 4(a) (Hancox and Walker, 1996).
We thought that a zwitterionic phosphorylating reagent
19 (Scheme 4(b)), reported by Asseline and Thuong (Asse-
line and Thuong et al., 1988), might be effective for the
phosphorylation of 17, because in the phosphorylation
MESSENGER 3, 35–51, 2014 39
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Scheme 4. Hydrolysis of 5′-dichlorophosphate B via intermediate
A (a) and zwitterionic phosphorylating reagent 19 (b).
intermediate C, the leaving ability of the phosphate moiety
would be decreased due to the negatively charged oxygen.
Thus, when 17 was treated with 19 in pyridine at −30 C
and then the reaction was quenched with triethylammo-
nium acetate (TEAA) buffer, a compound likely to be the
desired phosphorylated 18 was detected as a main peak
by HPLC analysis. The product, without purification, was
further treated with H3PO2 and Et3N in pyridine to remove
the phenylthio group (Hata et al., 1987) affording the phos-
phorylation product 5 after purification by ion-exchange
chromatography (Scheme 5).
With the S-phenyl phosphorothioate 5 in hand, we next
investigated the intramolecular cyclization reaction. When
a solution of 5 in pyridine was slowly added to a mixture
of a large excess of AgNO3 and Et3N in the presence of
MS3A in pyridine at room temperature (Fukuoka et al.,
2000; Shuto et al., 2001), the desired cyclization product
19 was obtained in 76% yield. Finally, removal of the iso-
propylidene groups of 19 with aqueous HCO2H produced
the target cADPtR (3) in 49% yield (Scheme 5).
Scheme 5. Synthesis of cADPtR (3).
Stability of cADPtR
cADPtR (3) appeared to be rather chemically stable, since
the final acidic removal of the isopropylidene groups of
20 was successful to produce cADPtR, as described above
(Scheme 5).
The biological stability of cADPtR was investigated
with a rat brain microsomal extract that contains cADPR
degradation enzymes (Lee and Aarhus, 1993). We first
treated cADPR with the extract at 37 C to result in its
rapid degradation. As expected, under the same condi-
tions, cADPtR was almost completely resistant to degrada-
tion in the extract. After 120 min treatment, approximately
90% of cADPR disappeared, whereas most of cADPtR
remained intact, indicating that cADPtR is stable under
physiological conditions (see Fig. 12).
pKa Value of cADPtR
The pKa value of cADPtR (3) was determined using a pre-
viously reported method (Kim et al., 1993). This method
is based on the pH-dependent UV spectral change between
285 nm and 300 nm area of cADPR or its analogs, due to
the protonation and proton-dissociation at the N6 position
of the adenine ring. As a result, the pKa of cADPtR was
determined to be 8.0, which was similar to that of cADPR
(pKa = 83) (Kim et al., 1993) and about 1 unit lower than
that of cADPcR (pKa = 89) (Guse et al., 2002).
Ca2+-Mobilizing Activity in Sea Urchin Egg
Homogenate
We tested the Ca2+-mobilizing ability of cADPtR (3) as
well as cADPR (1) and cADPcR (2) by fluorometrically
monitoring Ca2+ with H. pulcherrimus sea urchin egg
homogenate (Fig. 6) (Shiwa et al., 2002). cADPR released
Ca2+ from the homogenate in a concentration-dependent
manner with an EC50 value of 214 nM, and cADPcR
showed more potent activity (EC50 = 54 nM) than cADPR,
where the maximal Ca2+-mobilizing activity of cADPcR
was almost equal to that of cADPR. These results are con-
sistent with previous reports that cADPcR potently acti-
vates Ca2+ release in sea urchin eggs of A. crassispina
or L. pictus (Shuto etal., 2001; Kudoh et al., 2008). As
shown in Figure 6, cADPtR exhibited highly potent Ca2+-
mobilizing ability (EC50 = 36 nM), which was about 7-fold
more potent than the natural second messenger cADPR
and even more potent than cADPcR.
Ca2+-Mobilizing Activity in Neuronal Cells
The effect of cADPtR (3) on cytosolic Ca2+ mobiliza-
tion in NG108-15 neuronal cells was studied in per-
meabilized conditions using digitonin as the detergent
(Higashida et al., 1990; Amina et al., 2010). We first ver-
ified that extracellular application of digitonin itself did
40 MESSENGER 3, 35–51, 2014
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Figure 6. Concentration-dependent Ca2+-mobilizing activity
of cADPR, cADPcR, and cADPtR in sea urchin egg
homogenate. The Ca2+-mobilizing activity of each compound is
expressed as the percent change in ratio of fura-2 fluorescence
(F340/F380) relative to that of 10 M cADPR. Data are mean±
SEM of 3 to 6 experiments.
not cause an increase in [Ca2+]i in the conditions in which
the plasma membrane was permeabilized with 250 nM
of digitonin for nearly 5 min (Figs. 7(b) and (c)). We
also confirmed that application of 100 mM cADPR (1),
used as a positive control, caused a gradual and sustained
Ca2+ release in the digitonin-permeabilized conditions,
which allowed nucleotides to enter into the cytoplasm
(Fig. 8(c)). When cADPR was applied extracellularly to
intact NG108-15 cells, no increase in [Ca2+]i was detected
(data not shown). Figure 7(a) shows a representative field
of cells with [Ca2+]i changes induced by the application
of cADPtR with the plasma cell membrane was perme-
abilized with 250 nM digitonin for 5 min. Figure 8(c)
shows the mean time-course of [Ca2+]i changes induced
by cADPtR. Application of 100 M cADPtR induced per-
sistent increases in [Ca2+]i: the mean [Ca2+]i level mea-
sured 4 min after application of cADPtR was 116±2.3%
of the resting (pre-permeabilization) level (mean± SEM;
n= 6). The amplitude evoked by cADPtR was equivalent
to or significantly greater than that induced by cADPR:
the mean [Ca2+]i level measured 4 min after applica-
tion of cADPR was 107± 2.8% of the resting level (n=
10). A similar Ca2+-mobilizing pattern was observed in
cADPcR-applied cells: the mean [Ca2+]i level measured
4 min after application of cADPcR was 115±3.1% of the
resting level (n= 10).
These results in NG108-15 neuronal cells indicate that
cADPtR has potent Ca2+-mobilizing activity, similar to
cADPcR. Both cADPtR and cADPcR have increased effi-
cacy as compared with cADPR, which may be due to their
increased metabolic stability.
Ca2+-Mobilizing Activity in T Cells
The Ca2+-mobilizing effect of cADPtR (3) was evaluated
using saponin-permeabilized Jurkat T cells as reported
previously (Guse et al., 1993; Guse et al., 2007; Schwarz-
mann et al., 2002). Both cADPtR and cADPR (1) evoked
rapid Ca2+ release upon addition to the permeabilized
cell suspension indicating similar mechanisms of Ca2+
release (Fig. 8(a)). Though cADPR was somewhat more
potent at 100 mM, cADPR and cADPtR had very sim-
ilar concentration-response curves (Fig. 8(b)) indicating
that cADPtR binds to the cADPR receptor protein with
similar affinity. Our previous work revealed that replac-
ing the northern ribose of cADPR with the carbocyclic
moiety (cADPcR) shifted its Ca2+ mobilizing activity to
much higher concentrations (Guse et al., 2002). In con-
trast, the new analog cADPtR was almost as active as
cADPR. A difference of cADPcR and analog cADPtR are
their pKa values, amounting to 8.9 and 8.0, respectively.
Taking the pKa value of cADPR and the indistinguish-
able biological activity between cIDPR (4) and cADPR
(Moreau et al., 2006; Huang et al., 2002; Gu et al., 2004;
Xu et al., 2006) in T cells into account, the relatively high
biological activity of cADPtR might be in favour of the
imino form of cADPR being the active form of the natural
second messenger in T cells.
Conformational Analysis
The three-dimensional structures of biologically active
compounds in aqueous solution is very important from the
viewpoint of the bioactive conformation. Our study shows
that cADPR (1), cADPcR (2), and cADPtR (3) have dif-
ferent activities in sea urchin eggs, neuronal cells and T
cells, respectively. To investigate the biological difference
based on their conformations, structures of them were con-
structed by molecular dynamics calculations with a sim-
ulated annealing method based on the NOE constraints
of the intramolecular proton pairs measured in D2O (for
details, see Fig. 13). The structures obtained by the cal-
culations based on their observed NOE in the NOESY
spectra are shown in Figure 9.
To analyze the structural differences in more detail,
these structures were superimposed as shown in
Figure 10(a), which shows that the cADPtR structure
(red) resembles that of natural cADPR (blue). The cAD-
PcR structure (green), however, is not similar to those
of the other two compounds, in which the relative spe-
cial arrangement of the N1-thioribose ring and the ade-
nine ring is clearly different from those of the other two
compounds, as we expected. Thus, the distances between
the 4′′S between the adenine H2 of cADPtR (3.6 Å) is
significantly longer than the corresponding distances of
cADPR (2.3 Å) and cADPtR (2.5 Å), probably due to the
steric repulsion between the H6′′ with the adenine H2 in
cADPcR.
To confirm the validity of the obtained structures, we
used the cADPR structure solved by X-ray crystallo-
graphic analysis (2j, Lee et al., 1994). Thus, the X-ray
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Figure 7. Effects of cADPtR on [Ca2+]i increases in permeabilized NG108-15 cells. (a), (b) Cells were permeabilized by the addition
of 250 nM digitonin to the bath solution. cADPtR (final concentration, 100 M) (a) or an equal amount of buffer (b) was added together with
digitonin as indicated by the arrows. Representative fields are displayed for each condition. Changes in [Ca2+]i are shown as pseudocolor
images, and colors reflecting fluorescence intensities are indicated to the right together with arbitrary units. (c) Time-course of [Ca2+]i
changes in Oregon Green-loaded NG 108–15 cells. At about 25 s after the beginning of each trace, cell membranes were permeabilized
with buffers containing 250 nM digitonin with 100 M cADPtR (magenta), cADPcR (blue), cADPR (green), or without nucleotide as control
(black). Symbols indicate changes of [Ca2+]i levels for 5 min, represented by the fluorescence intensity at each time (x) divided by resting
intensity at time 0 (i.e., Fx/F0). For calculations, cells with mean fluorescence intensity of 90 to 130 at time 0 were selected. ∗, Values
in cells treated with cADPtR or cADPcR were significantly higher than those in control cells at p < 005. , Values in cells treated with
cADPtR were significantly higher than those in cells treated with cADPR at p < 005. (d) The graph shows concentration-dependent activity
of cADPtR (magenta), cADPcR (blue) and cADPR (green) in NG108-15 cells. Symbols indicate changes of [Ca2+]i levels at 280 s after
membrane permeabilization, represented by fluorescence intensity at each time divided by the resting state at time 0 (i.e., Fx/F0). Each
symbol is mean±SEM of 5 to 10 experiments. ∗, values significantly different from a drug-free control value (a gray circle) (P < 005). ,
Values in cells treated with cADPtR were significantly higher than those in cells with cADPR at p < 005.
structure of cADPR (white) is superimposed into the three
structures as shown in Figure 10(b). This crystal structure
resembles the calculated cADPR and cADPtR structures,
which suggests our structure determination by the molec-
ular dynamics calculations was done relevantly.
Discussion
cAPDtR (3), which was designed as a stable mimic
of cADPR (1), was successfully synthesized. In its
synthesis, the key N1--thioribosyladenosine structure
was effectively constructed by stereoselective condensa-
tion between the imidazole nucleoside derivative 8 and
the 4-thioribosylamine 7 via equilibrium between the
-anomer (7) and the -anomer (7). Also, the strat-
egy using a S-phenyl phosphorothioate-type substrate
in the intramolecular condensation reaction forming the
18-membered pyrophosphate linkage of cADPR-related
compounds is demonstrated to be useful in the present
case.
Although cADPR is rapidly hydrolyzed by cADPR
hydrolase to give ADP-ribose under physiological condi-
tions, cADPtR was shown to be biologically stable. Based
on the X-ray crystallographic analysis of the complex of
CD38 having cADPR hydrolase activity with nicotinamide
guanine dinucleotide (GDP+), Lee and Hao presented the
reaction mechanism of enzymatic cADPR hydrolysis via
an oxocarbenium intermediate, which is stabilized by the
hydroxy group of Ser196 of the enzyme catalytic site (Liu
et al., 2006). When an oxocarbenium ion, which is often an
intermediate in glycosidic bond cleavage, interacts with an
electronically negative nucleophilic atom such as oxygen
(the hydroxyl oxygen of Ser196 in the case of CD38), it
can be effectively stabilized by the adjacent ring oxygen of
the sugars due to n–p∗ hyperconjugation between the non-
bonding orbital on the ring oxygen and the vacant p-orbital
of anomeric carbon, that is known as the anomeric effect
(Juaristi and Cuevas, 1992; Thatcher, 1993; Juaristi and
Cuevas, 1995; Thibaudeau and Chattopadhyaya, 1999).
This stereoelectronic effect would promote enzymatic and
also chemical hydrolysis of cADPR at the N1-linkage.
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Figure 8. Effect of of cADPR (1) and cADPtR (3) on Ca2+ sig-
naling in permeabilized Jurkat T cells. After addition of fura-
2/free acid (1.5 mM) and charging of the intracellular Ca2+-pools
by the addition of ATP (1 mM) and an ATP-regenerating system
consisting of creatine phosphate (10 mM) and creatine kinase
(20 units/ml), the indicated concentrations of cADPR or cADP-4′′-
thio-ribose were added as indicated. (a) Representative tracings.
(b) Data presented as mean±SEM (n = 2 to 8).
On the other hand, the sulfur of thio-sugars, including
thioribose, would not so effectively stabilize the corre-
sponding thio-carbenium intermediates, because the hyper-
conjugation ability of sulfur is remarkably weaker than
that of oxygen (Salzner and Salzner, 1993), which can be
reason why cADPtR is more stable than cADPR.
On the other hand, the electron-withdrawing effect of
sulfur due to its electronically negative property effectively
lowered the pKa of cADPtR, and accordingly, its pKa is
similar to that of cADPR. Under physiological pH, the
population of the deprotonated imino form and the pro-
tonated amino form in cADPtR would be analogous that
Figure 9. Structures of cADPR (a), cADPcR (b), cADPtR (c) by molecular dynamics calculations with simulated annealing method
using the NOE data in D2O. Adenine H2 (white), O4
′′ in cADPR (red), C6′′ in cADPcR (green) and S4′′ in cADPtR (yellow) are shown in
sphere.
in cADPR. Therefore, the pKa value of cADPtR may be
favorable to exhibit its biological effects, similarly to nat-
ural messenger cADPR.
A difference of cADPcR and analog cADPtR are their
pKa values, amounting to 8.9 and 8.0, respectively. Taking
the pKa value of cADPR and the indistinguishable bio-
logical activity between cIDPR (4) and cADPR (Moreau
et al., 2006; Huang et al., 2002; Gu et al., 2004; Xu al.,
2006) in T cells into account, the relatively high biolog-
ical activity of cADPtR might be in favour of the imino
form of cADPR being the active form of the natural sec-
ond messenger in T cells.
Our conformational analysis revealed that cADPtR has
its three-dimensional structure analogous to cADPR due
the similar sp3 configuration of oxygen and sulfur bear-
ing two non-bonding electron pairs in the N1-ribose or
-thioribose ring, in which steric repulsion between the
three rings (adenine, N9-ribose, and N1-ribose) seems
to be minimal. Therefore, the structural and electro-
static features of cADPtR analogous to cADPR make
it as biologically active as cADPR in various systems
including T -cells, although the target proteins of cADPR
in these systems is considered to be different (Kudoh et al.,
2005).
Conclusion
We have successfully synthesized cADPtR (3) and demon-
strated that it is stable and functions as cADPR (1) in var-
ious biological systems, i.e., sea urchin egg homogenate,
neuronal cells and T cells. Because of the characteristic
stability and high potency of cADPtR, it, as a stable equiv-
alent of cADPR, can be useful as an effective tool for
identifying target proteins and for investigating cADPR-
mediated signaling pathways (Tsuzuki et al., 2013).
EXPERIMENTAL DETAILS
Chemical shifts are reported in ppm downfield from Me4Si
(1H), MeCN (13C) or H3PO4 (
31P). All of the 1H NMR
assignments described were in agreement with COSY
spectra. Thin-layer chromatography was done on Merck
coated plate 60F254. Silica gel chromatography was done
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Figure 10. Superimposed displays of the structures of
cADPR and its analogs. Only heavy atoms are shown. (a) Three
caluculated structures are superimposed: cADPR (blue), cADPcR
(green), and cADPtR (red). (b) Four structures were superimposed:
The crystal structure of cADPR (white), the calculated structures of
cADPR (blue), cADPcR (green), and cADPtR (red).
on Merck silica gel 5715. Reactions were carried out under
an argon atmosphere.
1,4-Dideoxy-1,4-Episulfinyl-2,3-O-Isopropylidene-
D-Ribitol (10)
To a solution of 22 (1.90 g, 10.0 mmol) in CH2Cl2
(30 mL) was added slowly a solution of mCPBA (3.18 g,
12.0 mmol) in CH2Cl2 (60 mL) at −78 C, and the mix-
ture was stirred at the same temperature for 20 min. To
the mixture was added aqueous Na2S2O3, and the result-
ing mixture was partitioned between EtOAc and H2O,
and the organic layer was washed with aqueous satu-
rated NaHCO3 and brine, dried (Na2SO4), and evapo-
rated. The residue was purified by column chromatography
(SiO2, hexane/AcOEt= 3/1 then 1/1) to give 10 (1.88 g,
91%, white amorphous solid): 1H-NMR of one isomer
(500 MHz, CDCl3 1.33 (3 H, s, isopropylidene-CH3),
1.47 (3 H, s, isopropylidene-CH3), 3.29 (1 H, dd, J =
143, 6.3 Hz, H-1), 3.42 (1 H, ddd, J = 57, 5.7, 2.9 Hz,
H-4), 3.45 (1 H, dd, J = 143, 5.7 Hz, H-1) 4.10 (1 H, dd,
J = 126, 5.7 Hz, H-5), 4.34 (1 H, dd, J = 126, 2.9 Hz,
H-5), 4.80 (1 H, br, OH), 5.10 (1 H, dd, J = 57, 3.4 Hz,
Figure 11. NOE and HMBC data of 6b and 6a.
Figure 12. Stability of cADPtR and cADPR in rat brain micro-
some extract.
H-3), 5.20 (1 H, ddd, J = 63, 5.7, 3.4 Hz, H-2); 13C-
NMR (125 MHz, CDCl3 24.61, 27.12, 57.06, 57.06,
58.11, 65.63, 79.76, 82.22, 112.11; HR-MS (EI) calcd for
C8H14O4S2206.06128 (M
+), found 206. 06169.
1,5-O-Diacetyl-2,3-O-Isopropylidene-4-Thio-D-
Ribose (11)
A solution of 10 (135 mg, 0.44 mmol) in Ac2O (3 mL) was
heated at 100 C for 28 h, and then evaporated. The residue
was partitioned between EtOAc and H2O, and the organic
layer was washed with queous saturated NaHCO3 and
brine. The aqueous layers were combined and extracted
with CHCl3. The organic layers were combined, dried
(Na2SO4), and evaporated. The residue was purified by
column chromatography (SiO2, hexane/AcOEt= 6/1, 3/1
then 1/1) to give 11 (93 mg, 64%, J = 115, 5.7 Hz, H-5),
4.89–4.91 (2 H, m, H-2, H-3), 6.04 (1 H, s, H-1), for -
anomer,  1.36 (3 H, s, isopropylidene-CH3), 1.54 (3 H,
s, isopropylidene-CH3), 2.10 (3 H, s, Ac), 2.15 (3 H, s,
Ac), 3.90 (1 H, m, H-4), 4.19 (1 H, dd, J = 115, 6.3 Hz,
H-5), 4.35 (J = 115, 5.7 Hz, H-5), 4.89–4.91 (2 H, m,
H-2, H-3), 6.04 (1 H, s, H-1), for -anomer,  1.36 (3 H,
s, isopropylidene-CH3), 1.54 (3 H, s, isopropylidene-CH3),
2.10 (3 H, s, Ac), 2.15 (3 H, s, Ac), 3.90 (1 H, m, H-4),
4.19 (1 H, dd, J = 115, 6.3 Hz, H-5), 4.35 (1 H, dd,
J = 115, 6.3 Hz, H-5), 4.67 (1 H, dd, J = 63, 4.0 Hz,
H-3), 4.88 (1 H, m, H-2), 6.09 (1 H, d, J = 52 Hz, H-1)
13C-NMR (100 MHz, CDCl3 20.85, 21.21, 24.61, 26.38,
53.85, 65.71, 85.13, 87.17, 88.54, 111.29, 169.16, 170.49;
HR-MS (FAB, positive) calcd for C12H18NaO6S 313.0722
[(M+Na)+], found 313.0717.
5-O-Acetyl-2,3-O-Isopropylidene-4-Thio--D-
Ribofuranosylazide (12)
To a solution of 11 (2.26 g, 7.78 mmol) and TMSN3
(3.09 mL, 23.3 mmol) in CH2Cl2 (20 mL) was added
a solution of SnCl4 (223 mL, 1.91 mmol) in CH2Cl2
(10 mL) at 0 C, and the mixture was stirred at the
44 MESSENGER 3, 35–51, 2014
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Figure 13. Important correlations in NOESY spectra of (a) cADPR (1), (b) cADPcR (2), (c) cADPtR (3), used for the calculations.
same temperature for 5 min. To the mixture was added
aqueous saturated NaHCO3, and the resulting white pre-
cipitate was filtered off with Celite. The filtrate was
washed with aqueous saturated NaHCO3 and brine, dried
(Na2SO4), and evaporated. The residue was purified by
column chromatography (SiO2, hexane/AcOEt= 20/1) to
give 12 (1.84 g, 86%, yellow oil): 1H-NMR (400 MHz,
CDCl3 1.31 (3 H, s, isopropylidene-CH3), 1.50 (3 H,
s, isopropylidene-CH3), 2.11 (3 H, s, Ac), 3.63 (1 H, dd,
J = 100, 5.4 Hz, H-4), 4.12 (1 H, dd, J = 113, 10.0 Hz,
H-5), 4.27 (1 H, dd, J = 113, 5.4 Hz, H-5), 4.64 (1 H,
d, J = 54 Hz, H-3), 4.86 (1 H, d, J = 54 Hz, H-2),
5.18 (1 H, s, H-1); 13C-NMR (100 MHz, CDCl3 20.73,
24.51, 26.26, 54.29, 65.21, 76.13, 85.59 89.06, 111.23,
170.40; HR-MS (FAB, positive) calcd for C10H15N3NaO4S
296.0681 [(M+H)+], found 296.0695.
2,3-O-Isopropylidene-4-Thio-D-
Ribofuranosylamine (7)
A mixture of 12 (1.25 g, 4.57 mmol) and Pd/C (10%,
630 mg) in MeOH (45 mL) was stirred under atmospheric
pressure of H2 at room temperature for 1 h, and then
the catalysts were filtered off with Celite. The filtrate was
evaporated, and the residue was purified by column chro-
matography (NH-silica gel, hexane/AcOEt= 6/1, 2/1 then
1/3) to give 7 (1.09 g, quant., / = 1/2, brown oil):
1H-NMR (500 MHz, CDCl3 1.30 (2 H, s), 1.36 (1 H,
s), 1.52, (2 H, s), 1.57 (1 H, s), 1.83 (2 H, brs), 3.58
(2/3 H, dd, J = 77, 5.4 Hz), 3.73 (1/3 H, ddd, J =
63, 5.9 Hz), 4.32 (2/3 H, dd, J = 117, 7.7 Hz), 4.43
(2/31 H, dd, J = 117, 5.4 Hz), 4.49 (1/3 H, dd, J =
113, 5.9 Hz), 4.60–4.66 (2/3 H, m), 4.71–4.74 (1 H, m),
4.79 (2/3 H, d, J = 52 Hz, b–H–1), 4.92 (1/3 H, dd,
J = 45 Hz), 5.04 (2/3 H, d, J = 45 Hz); 13C-NMR
(100 MHz, CDCl3 −5.64, −5.51, 18.23, 24.36, 25.27,
25.80, 26.50, 27.22, 57.20, 63.68, 64.31, 64.63, 81.06,
85.99, 86.45, 87.57, 91.20, 91.65, 95.13, 110.33, 113.74,
117.26, 132.20, 148.52, 151.04; HR-MS (EI) calcd for
C8H15NO3S 205.0773 (M
+), found 205.0773.
N1-(2,3-O-isopropylidene-4-thio--D-
ribofuranosyl)-5′′-O-(tert-butyldimethylsilyl)-2′,3′-
O-Isopropylideneadenosine (6)
A solution of 7 (381 mg, 1.87 mmol) and 8 (1.79 g,
4.00 mmol) in MeOH (10 mL) was stirred at room
temperature for 10 h, and then evaporated. The residue
was purified by flash column chromatography (silica gel,
hexane/AcOEt= 1/2, AcOEt , then AcOEt/MeOH = 9/1)
to give 6 (700 mg, 61%, white amorphous solid), 6
(59 mg, 5%, white amorphous solid), 14 (30 mg, 4%, yel-
low amorphous solid). 6: 1H-NMR (500 MHz, CDCl)
0.04 (3 H, s, Si-CH3), 0.05 (3 H, s, Si-CH3), 0.86 (9H, s,
tert-b tyl), 1.35 (3 H, s, isopropylidene-CH3), 1.39 (3 H,
s, isopropylidene-CH3), 1.61 (3 H, s, isopropylidene-CH3),
1.63 (3 H, s, isopropylidene-CH3), 3.77 (1 H, dd, J = 114,
4.0, 4.0 Hz, H-5′), 3.83–3.88 (2 H, m, H-5′, H-5′′), 3.90
(1 H, m, H-4′′), 4.01 (1 H, dd, J = 114, 3.7 Hz, H-5′′),
4.39 (1 H, m, H-4′), 4.88 (1 H, dd, J = 63, 3.4 Hz, H-3′),
4.99 (1 H, dd, J = 52, 1.7 Hz, H-3′′), 5.06 (1 H, dd,
J = 63, 2.3 Hz, H-2′), 5.51 (1 H, dd, J = 52, 3.4 Hz,
H-2′′), 6.00 (1 H, d, J = 34 Hz, H-1′′), 6.02 (1 H, d, J =
23 Hz, H-1′), 7.85 (1 H, s, H-8), 7.88 (1 H, s, H-2); 13C-
NMR (125 MHz, CDCl3 −5.58, −5.47, 18.25 25.25,
25.80, 27.13, 27.92, 55.53, 63.37, 64.75, 74.54, 81.19,
85.23, 85.75, 86.22, 86.95, 91.15, 111.66, 114.09, 123.75,
137.20, 140.30, 146.81, 153.31; UV (MeOH) max =
260 nm; LR-MS (FAB, positive) m/z 610 [(M+H)+];
Anal. Calcd for C27H43N5O7SSi: C, 53.18; H, 7.11, N,
11.48. Found C, 52.88; H, 6.95; N, 11.35; NOE irradi-
ated H-2/ observed H-2′′ (3.8%), irradiated H-1′′/observed
H-4′′ (2.3%), irradiated H-2′′/ observed H-2 (4.7%), irradi-
ated H-4′′/ observed H-1′′ (3.2%). 6: 1H-NMR (500 MHz,
CDCl) 0.05 (3 H, s, Si-CH3), 0.05 (3 H, s, Si-CH3), 0.87
(9H, s, tert-butyl), 1.35 (3 H, s, isopropylidene-CH3), 1.39
(3 H, s, isopropylidene-CH3), 1.61 (3 H, s, isopropylidene-
CH3), 1.63 (3 H, s, isopropylidene-CH3), 3.56 (1 H, d,
J = 41, 4.1 Hz, H-4′′), 3.76 (1 H, dd, J = 113, 3.6 Hz,
H-5′), 3.84–3.88 (2 H, m, H-5′, H-5′′), 3.93 (1 H, dd,
J = 109, 4.1 Hz, H-5′′), 4.39 (1 H, ddd, J = 63, 3.6,
3.6 Hz, H-4′), 4.90 (1 H, dd, J = 63, 2.7 Hz, H-3′),
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Cyclic ADP-4-Thioribose Tsuzuki et al.
4.95 (1 H, d, J = 59 Hz, H-3′′), 5.01 (1 H, dd, J = 59,
4.5 Hz, H-2′′), 5.09 (1 H, dd, J = 63, 2.7 Hz, H-2′), 6.05
(1 H, d, J = 27 Hz, H-1′), 7.02 (1 H, d, J = 45 Hz,
H-1′′), 7.83 (1 H, s, H-8), 8.42 (1 H, s, H-2); 13C-NMR
(125 MHz, CDCl3 −5.54, −5.44, 18.29, 24.22, 25.33,
25.83, 25.97, 27.16, 54.36, 61.15, 63.34, 65.17, 80.59,
81.19, 85.30, 85.87, 86.99, 91.16, 111.38, 114.09, 122.77,
136.83, 140.88, 147.76, 155.00; UV (MeOH) max =
259 nm; HR-MS (FAB, positive) calcd for C28H43N5O7SSi
610.2731 (MH+), found 610.2727. NOE irradiated H-2/
observed H-4′′ (1.0%), irradiated H-1′′/observed H-2′′
(10.7%), irradiated H-2′′/observed H-1′′ (8.4%), irradi-
ated H-4′′/observed H-2 (1.7%). 13: 1H-NMR (500 MHz,
CDCl3)  0.00 (3 H, s, Si–CH3), 0.01 (3 H, s, Si–CH3),
0.83 (9H, s, tert-butyl), 1.32 (3 H, s, isopropylidene-
CH3), 1.40 (3 H, s, isopropylidene-CH3), 1.59 (3 H, s,
isopropylidene-CH3), 1.62 (3 H, s, isopropylidene-CH3),
3.69 (1 H, m, H-4′′), 3.73 (1 H, dd, J = 113, 4.5 Hz,
H-5′), 3.83–3.87 (2 H, m, H-5′, H-5′′), 3.90 (1 H, br, OH),
4.07 (1 H, dd, J = 104, 2.7 Hz, H-5′′), 4.39 (1 H, m, H-
4′), 4.87 (1 H, d, J = 50 Hz, H-2′), 4.94–4.96 (2 H, m,
H-3′, H-3′′), 5.28 (1 H, dd, J = 63, 2.3 Hz, H-2′), 6.13
(1 H, d, J = 23 Hz, H-1′), 6.16 (1 H, br, H-1′′), 7.49
(1 H, d, J = 91 Hz, NH), 7.97 (1 H, s, H-2), 8.45 (1 H,
s, H-8); 13C-NMR (125 MHz, CDCl3 −5.64, −5.51,
18.23, 24.36, 25.27, 25.80, 26.50, 27.22, 57.20, 63.68,
64.31, 64.63, 81.06, 85.99, 86.45, 87.57, 91.20, 91.65,
95.13, 110.33, 113.74, 117.26, 132.20, 148.52, 151.04; UV
(MeOH) max = 273 nm; HR-MS (FAB, positive) calcd for
C27H44N5O7SSi 610.2731 (MH
+), found 610.2741.
N1-(2,3-O-isopropylidene-4-thio-5-O-
dimethoxytrityl--D-ribofuranosyl)-
5′-O-(tert-butyldimethylsilyl)-2′,3′-O-
Isopropylideneadenosine (14)
A solution of 6 (889 mg, 1.46 mmol) and DMTrCl
(989 mg, 2.92 mol) in pyridine (5 mL) was stirred at
room temperature for 12 h. After addition of MeOH,
the resulting mixture was partitioned between EtOAc and
1 M aqueous HCl, and the organic layer was washed
with H2O and brine, dried (Na2SO4), and evaporated.
The residue was purified by column chromatography
(silica gel, hexane/AcOEt = 6/1, 3/1, 3/2, and 2/3) to
give 14 (1.08 g, 81%, white amorphous solid): 1H-
NMR (500 MHz, CDCl3 0.05 (3 H, s, Si–CH3), 0.06
(3 H, s, Si–CH3), 0.88 (9H, s, tert-butyl), 1.30 (3 H,
s, isopropylidene-CH3), 1.38 (3 H, s, isopropylidene-
CH3), 1.59 (3 H, s, isopropylidene-CH3), 1.62 (3 H, s,
isopropylidene-CH3), 3.40–3.46 (2 H, m, H-5
′′ × 2), 3.77
(1 H, m, H-5′), 3.78 (3 H, s, OCH3), 3.78 (3Hy, s, OCH3),
3.80–3.85 (2 H, m, H-4′′, H-5′), 4.38 (1 H, ddd, J =
57, 4.0, 4.0 Hz, H-4′), 4.72 (1 H, dd, J = 57, 4.0 Hz,
H-3′′), 4.86 (1 H, dd, J = 63, 5.7 Hz, H-3′), 4.89 (1 H,
dd, J = 57, 2.3 Hz, H-2′′), 4.97 (1 H, dd, J = 63,
2.9 Hz, H-2′) 6.02 (1 H, d, J = 29 Hz, H-1′), 6.52 (1 H,
d, J = 23 Hz, H-1′′), 6.81–7.47 (13 H, m, Ar), 7.82
(1 H, s, H-8), 8.12 (1 H, s, H-2); 13C-NMR (125 MHz,
CDCl3 −5.58, −5.47, 18.22, 25.21, 25.28, 25.79, 27.13,
27.35, 54.95, 55.05, 63.30, 64.85, 66.78, 81.06, 84.82,
85.25, 86.53, 86.79, 89.22, 90.86, 112.38, 113.03, 113.05,
114.01, 123.23, 126.66, 127.73, 127.95, 129.92, 129.96,
135.46, 135.60, 136.51, 140.35, 144.47, 145.55, 153.98,
158. 37; LR-MS (FAB, positive) m/z 882 [(M+H)+]; UV
(MeOH) max = 259 nm; Anal. Calcd for C48H61N5O9SSi:
C, 63.20; H, 6.74, N, 7.68. Found C, 63.19; H, 6.91; N,
7.39.
N1-(2,3-O-isopropylidene-4-thio-5-O-
dimethoxytrityl--D-ribofuranosyl)-2′,3′-O-
Isopropylideneadenosine (15)
A solution of 14 (94 mg, 103 mmol), TBAF (1.0 M in
THF, 200 mL, 0.20 mmol) and AcOH (6 L, 1 mol) in
THF (800 mL) was stirred at room temperature for 9 h,
and then evaporated. The residue was purified by column
chromatography (silica gel, hexane/AcOEt= 2/1, /1, 3/2,
and 1/3) to give 15 (83 mg, quant., colorless amorphous
solid): 1H-NMR (500 MHz, CDCl3 1.29 (3 H, s, iso-
propylidene), 1.37 (3 H, s, isopropylidene), 1.58 (3 H, s,
isopropylidene), 1.63 (3 H, s, isopropylidene), 3.40 (1 H,
dd, J = 97, 6.9 Hz, H-5′′), 3.46 (1 H, dd, J = 97, 6.9 Hz,
H-5′′), 3.72 (1 H, dd, J = 126, 10.9 Hz, H-5′′), 3.77 (3 H,
s, OCH3), 3.77 (3 H, s, OCH3), 3.79 (1 H, m, H-4
′′),
3.86 (1 H, d, J = 126 Hz, H-5′), 4.47 (1 H, m, H-4′),
4.67 (1 H, dd, J = 57 4.0 Hz, H-3′′), 4.84 (1 H, dd, J =
57, 2.3 Hz, H-2′′), 4.99–5.03 (2 H, m, H-2′, H-3′), 5.31
(1 H, d, J = 109 Hz, OH), 5.75 (1 H, d, J = 46 Hz,
H-1′), 6.44 (1 H, d, J = 23 Hz, H-1′′), 6.80–7.42 (13Hy,
m, Ar), 7.57 (1 H, br s, NH), 7.63 (1 H, s, H-8), 8.14
(1 H, s, H-2); 13C-NMR (125 MHz, CDCl3 25.42, 25.48,
27.60, 27.76, 54.98, 55.39, 63.28, 65.05, 67.35, 81.62,
83.90, 84.89, 86.03, 86.90, 89.28, 93.95, 112.90, 113.35,
114.39, 125.04, 127.03, 128.07, 128.26, 130.18, 130.23,
135.74, 135.92, 138.32, 139.63, 144.66, 146.01, 153.86,
158.70; UV (MeOH) max = 258 nm; HR-MS (FAB, pos-
itive) calcd for C42H48N5O9S 798.3173 [(M+H)+], found
798.3193.
N1-(2,3-O-isopropylidene-4-thio-5-O-
dimethoxytrityl--D-ribofuranosyl)-5′-
O-[bis(phenylthio)phosphoryl]-2′,3′-O-
Isopropylideneadenosine (16)
To a solution of 15 (845 mg, 1.06 mmol) in pyridine
(5 mL) was added a solution of PSS (809 mg, 2.12 mmol)
and TPSCl (693 mg, 1.91 mmol) in pyridine (5 mL) at
−15 C, and the mixture was stirred at the same tempera-
ture for 2.5 h. After addition of H2O, the resulting mixture
was partitioned between EtOAc and 1 M aqueous HCl,
and the organic layer was washed with H2O and brine,
46 MESSENGER 3, 35–51, 2014
Delivered by Publishing Technology to: University of Bath
IP: 138.38.54.40 On: Tue, 14 Jul 2015 12:40:56
Copyright: American Scientific Publishers
M
E
S
S
E
N
G
E
R
M
E
S
S
E
N
G
E
R
M
E
S
S
E
N
G
E
R
M
E
S
S
E
N
G
E
R
M
E
S
S
E
N
G
E
R
M
E
S
S
E
N
G
E
R
Tsuzuki et al. Cyclic ADP-4-Thioribose
dried (Na2SO4), and evaporated. The residue was purified
by column chromatography (silica gel, hexane/AcOEt =
3/1, 1/1, 1/2, and 1/3) to give 16 (812 mg, 72%, white
amorphous solid): 1H-NMR (500 MHz, CDCl3 1.25
(3 H, s, isopropylidene-CH3), 1.36 (3 H, s, isopropylidene-
CH3), 1.57 (3 H, s, isopropylidene-CH3), 1.61 (3 H, s,
isopropylidene-CH3), 3.40 (1 H, m, H-5
′), 3.46 (1 H, dd,
J = 92, 5.7 Hz, H-5′), 3.77 (3 H, s, OCH3), 3.77 (3 H,
s, OCH3), 3.79 (1 H, m, H-4
′′), 4.37–4.39 (2 H, m, H-
5′′ × 2), 4.44 (1 H, m, H-4′), 4.64 (1 H, m, H-3′′), 4.83
(1 H, dd, J = 63, 2.3 Hz, H-2′′), 4.89 (1 H, dd, J = 63,
3.4 Hz, H-3′), 5.06 (1 H, dd, J = 63, 2.3 Hz, H-2′), 5.97
(1 H, d, J = 23 Hz, H-1′), 6.55 (1 H, d, J = 23 Hz,
H-1′′), 6.80–7.48 (23 H, m, Ar), 7.82 (1 H, s, H-8), 8.09
(1 H, s, H-2); 13C-NMR (125 MHz, CDCl3 25.32, 27.14,
27.48, 55.09, 55.19, 64.99, 66.14, 66.33, 66.39, 80.89,
84.44, 84.70, 84.79, 86.58, 89.09, 90.62, 112.59, 113.12,
113.15, 123.71, 125.67, 125.71, 125.73, 125.76, 126.79,
127.85, 128.10, 129.42, 129.44, 129.63, 129.66, 129.68,
129.70, 130.03, 130.08, 135.11, 135.16, 135.27, 135.31,
135.58, 135.71, 137.27, 140.28, 144.55, 145.85, 153.96,
158.47; 31P-NMR (202 MHz, CDCl3) d 50.79 (s); UV
(MeOH) max = 258 nm; HR-MS (FAB, positive) calcd for
C54H57N5O10PS3 1062.3005 [(M+H)+], found 1062.2999.
N1-(2,3-O-isopropylidene-4-thio--D-
ribofuranosyl)-5′-O-[bis(phenylthio)phosphoryl]-
2′,3′-O-Isopropylideneadenosine (17)
A solution of 16 (23 mg, 22 mmol) in aqueous 60%
AcOH (2 mL) was stirred at room temperature for 4 h,
and then evaporated. The residue was purified by column
chromatography (silica gel, hexane/AcOEt= 1/1, 1/3, then
AcOEt) to give 17 (15 mg, colorless amorphous solid): 1H-
NMR (500 MHz, CDCl3 1.34 (3 H, s, isopropylidene-
CH3), 1.38 (3 H, s, isopropylidene-CH3), 1.60 (3 H, s,
isopropylidene-CH3), 1.62 (3 H, s, isopropylidene-CH3),
3.76–3.83 (3 H, m, H-4′′, H-5′′ ×2), 4.30 (1 H, ddd, J =
114, 9.7, 5.2 Hz, H-5′), 4.43 (1 H, ddd, J = 63, 5.2,
2.9 Hz, H-4′), 4.47 (ddd, 1 H, J = 126, 9.7, 6.3 Hz,
H-5′), 4.83 (1 H, d, J = 52 Hz, H-3′′), 5.04 (1 H, dd,
J = 63, 2.9 Hz, H-3′), 5.09 (1 H, dd, J = 52, 1.1 Hz,
H-2′′) 5.28 (1 H, dd, J = 63, 1.7 Hz, H-2′), 5.98 (1 H,
d, J = 17 Hz, H-1′), 6.07 (1 H, d, J = 11 Hz, H-1′′),
7.27–7.54 (10H, m, Ar), 7.63 (1 H, s, H-8), 8.55 (1 H, s,
H-2); 13C-NMR (125 MHz, CDCl3) d 24.88, 25.08, 26.87,
27.28, 57.09, 64.26, 66.26, 66.32, 73.96, 81.93, 84.52,
85.65, 85.73, 85.93, 89.68, 91.39, 110.99, 114.10, 123.84,
125.28, 125.34, 125.46, 125.52, 129.27, 129.29, 129.38,
129.40, 129.58, 129.60, 129.73, 129.75, 135.04, 135.09,
135.37, 135.40, 138.01, 140.22, 147.09, 154.09; 31P-NMR
(202 MHz, CDCl3) d 52.23 (s); UV (MeOH) max = 251,
258 nm; HR-MS (FAB, positive) calcd for C33H39N5O8PS3
760.1698 [(M+H)+], found 760.1710.
N1-(2,3-O-isopropylidene-4-thio-5-O-phospholyl-
-D-ribofuranosyl)-5′-O-(phenylthiophosphoryl)-
2′,3′-O-Isopropylideneadenosine (5)
A solution of MeOPOCl2 (30 mL, 0.30 mmol) in pyri-
dine (1 mL) was stirred at −15 C for 15 min. To the
solution was added a solution of 17 (75 mg, 0.10 mol)
in pyridine (1 mL), and the mixture was stirred at the
same temperature for 2 h. To the resulting solution was
added triethylammonium acetate (TEAA) buffer (0.5 M,
pH 7.0, 3 mL) then H3PO2 (101 L, 2.0 mmol) and
Et3N (140 L, 1.0 mmol), and the mixture was stirred
at room temperature for 13 h, and then evaporated. The
residue was partitioned between EtOAc and H2O, and the
aqueous layer was evaporated. The residue was purified
by column chromatography (ODS, 1.2× 16 cm, 0–37%
CH3CN/0.1 M TEAA buffer (0.1 M, pH 7.0, 400 mL),
linear gradient). The excess TEAA included in the residue
was removed by column chromatography (ODS, 1.2×
16 cm, CH3CN/H2O = 1/1). The product was lyophilized
to give 5 (37 mg, 512 OD260 unit, 46%) as a triethylam-
monium salt: 1H-NMR (500 MHz, D2O) 1.26 (9H, t,
J = 74 Hz (CH3CH2)3N), 1.40 (3 H, s, isopropylidene-
CH3), 1.43 (3Hy, s, isopropylidene-CH3), 1.63 (3 H, s,
isopropylidene-CH3), 1.69 (3Hy, s, isopropylidene-CH3),
3.18 (6H, q, J = 74 Hz, (CH3CH23N), 4.10–4.13 (4H,
m, H-4′′, H-5′ ×2, H-5′′), 4.70 (1 H, m, H-4′′), 4.20 (1 H,
m, H-5′), 4.22 (1 H, m, H-5′′), 4.32 (1 H, m, H-5′′), 4.71
(1 H, m, H-4′), 4.94 (1 H, d, J = 52 Hz, H-3′) 5.12–5.15
(2 H, m, H-2′′, H-3′′), 5.42 (1 H, dd, J = 63, 2.9 Hz,
H-3′), 5.39 (1 H, d, J = 52 Hz, H-2′), 5.95 (1 H, s,
H-1′′), 6.37 (1 H, s, H-1′), 7.19–7.33 (5H, m, Ar), 8.41
(1 H, s, 8-H), 9.24 (1 H, s, 2-H); 13C-NMR (125 MHz,
D2O) 8.30, 24.32, 24.35, 25.95, 26.41, 46.71, 54.48,
54.55, 65.90, 65.95, 66.59, 66.62, 75.84, 81.39, 84.11,
86.19, 86.27, 86.52, 89.30, 90.88, 113.51, 114.72, 119.08,
127.91, 129.08, 129.47, 129.51, 132.75, 132.79, 143.02,
145.48, 146.84, 150.53; 31P-NMR (202 MHz, D2O) d
17.54 (s), 0.80 (s); UV (D2O) max = 258 nm; HR-MS
(FAB, negative) calcd for C27H34N5O12P2S2746.1126 [(M-
H)−], found 746.1106.
Cyclic ADP-4-Thio-Ribose 2′,3′-,
2′′,3′′-Bisacetonide (19)
To a mixture of AgNO3 (36 mg, 0.21 mmol), Et3N
(29 ml, 0.21 mmol), and MS 3A (powder, 1.0 g) in
pyridine (8 mL), a solution of 5 (9 mg, 50 OD260 unit,
4 mmol) in pyridine (8 mL) was added slowly over 15 h,
using a syringe-pump, at room temperature under shad-
ing. To the mixture was added TEAA buffer (2.0 M,
pH 7.0, 2 mL), and the resulting mixture was filtered
with Celite and evaporated. The residue was partitioned
between EtOAc and H2O, and the aqueous layer was
evaporated, and the residue was purified by column chro-
matography (ODS, 1.2× 16 cm, 0–35% CH3CN/0.1 M
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Cyclic ADP-4-Thioribose Tsuzuki et al.
TEAA buffer (0.1 M, pH 7.0, 400 mL), linear gra-
dient). The excess TEAA included in the residue was
removed by column chromatography (ODS, 1.2× 16 cm,
CH3CN/H2O = 1/1). The product was lyophilized to give
19 (6 mg, 36 OD260 unit, 72%) as a triethylammonium
salt: 1H-NMR (500 MHz, D2O) 1.24 (9H, t, J = 74 Hz
(CH3CH23N), 1.41 (3 H, s, isopropylidene-CH3), 1.43
(3 H, s, isopropylidene-CH3), 1.61 (3 H, s, isopropylidene-
CH3), 1.65 (3 H, s, isopropylidene-CH3), 3.17 (6H, q, J =
74 Hz, (CH3CH23N), 3.91 (1 H, m, H-5
′), 4.13 (1 H,
m, H-4′′), 4.20 (1 H, m, H-5′), 4.22 (1 H, m, H-5′′),
4.32 (1 H, m, H-5′′), 4.58 (1 H, m, H-4′), 5.07 (1 H, d,
J = 48 Hz, H-3′′) 5.13 (1 H, d, J = 48 Hz, H-2′′), 5.42
(1 H, dd, J = 63, 2.9 Hz, H-3′), 5.89 (1 H, dd, J = 63,
1.7 Hz, H-2′), 5.99 (1 H, s, H-1′′), 6.38 (1 H, d, J =
17 Hz, H-1′), 8.38 (1 H, s, 8-H), 9.59 (1 H, s, 2-H);
13C-NMR (125 MHz, D2O) 8.29, 24.39, 24.42, 26.07,
26.26, 46.73, 55.40, 55.49, 64.80, 68.03, 64.83, 68.00,
77.65, 81.36, 83.25, 86.65, 86.73, 87.34, 90.82, 91.45,
113.11, 114.59, 119.58, 144.91, 145.55, 147.20, 150.67;
31P-NMR (202 MHz, D2O) d −10.62 (d, J = 155 Hz), d
−11.29 (d, J = 155 Hz); UV (D2O) max = 258 nm; HR-
MS (FAB, negative) calcd for C21H28N5O12P2S 636.0936
[(M-H)−], found 636.0947.
Cyclic ADP-4-Thio-Ribose (3)
A solution of 19 (280 OD260 unit, 25 mmol) in aque-
ous 60% HCO2H (1 mL) was stirred at room temperature
for 40 h and then evaporated. After co-evaporation with
H2O, the residue was purified by column chromatogra-
phy (ODS, 1.2× 16 cm, TEAA buffer (5 mM, pH 7.0)).
The excess TEAA included in the residue was removed by
column chromatography (Sephadex LH 20, 2.5× 20 cm,
H2O) to give 3 as a triethylammonium salt, which was con-
verted into a free acid form by passing through columns
of Daiaion PK212L (H+ form, 0.7 cm×5 cm, H2O). The
free acid was passed throuh Chelex 100 column (K+ form,
0.7 cm× 6 cm, H2O). The eluent was evapolated and
lyophilized to give 3 (138 OD260 unit, 49%) as a potas-
sium salt. 3 (potassium salt): 1H-NMR (500 MHz, D2O)
 3.59 (1 H, dd, J = 82, 3.2 Hz), 4.08 (1 H, m), 4.19
(1 H, m), 4.24–4.36 (4H, m), 4.52 (1 H, ddd J = 104, 8.2,
2.7 Hz), 4.60 (1 H, dd, J = 54, 2.3 Hz), 5.18 (1 H, dd,
J = 59, 5.4 Hz), 5.87 (2 H, m), 7.97 (1 H, s), 9.25 (1 H,
s); 13C-NMR (125 MHz, D2O) 50.8, 50.9, 63.1, 65.0,
65.0, 70.1, 70.6, 72.6, 73.0, 78.3, 84.7, 84.8, 90.5, 120.0,
145.3, 145.9, 146.9, 150.8; 31P-NMR (162 MHz, D2O)
−9.15 (d, J = 122 Hz),  −10.20 (d, J = 122 Hz); UV
(D2O) max = 258 nm; HR-MS (FAB, negative) calcd for
C15H20N5O12P2S 556.0304 [(M-H)
−], found 556.2994. 3
(free acid): 1H-NMR (500 MHz, D2O) 3.72 (1 H, ddd,
J = 52, 3.4, 1.7 Hz), 4.09 (1 H, ddd, J = 109, 6.9,
2.9 Hz), 4.25 (1 H, ddd, J = 115, 5.2, 2.3 Hz), 4.35–4.39
(3 Hy, m), 4.51 (1 H, ddd, J = 109, 7.4, 4.0 Hz), 4.53
(1 H, dd, J = 59, 2.9 Hz), 4.71 (1 H, dd, J = 52, 2.3 Hz),
5.22 (1 H, dd, J = 63, 5.2 Hz), 5.97 (1 H, d, J = 29 Hz),
6.04 (1 H, d, J = 63 Hz), 8.38 (1 H, s), 9.90 (1 H, s).
Stability in Rat Brain Microsomes
Rat brain microsomes were prepared by a procedure
according to the previous method (Murayama, T. and
Ogawa Y. (1996). J. Biol. Chem. 271, 5079–5084.).
cADPR or cADPtR (1.6 OD260 unit) was preincubated in
20 mM MOPS buffer (pH 7.1, 160 L) at 37 C for
5 min. This was added to the solution of the microsome
fraction of rat brain extract (14.9 mg/mL, 140 L), and
the mixture was incubated at 37 C. The reaction mix-
ture was sampled (25 L) at every 30 min afterwards and
diluted with water (175 L), which was frozen in liquid
nitrogen to stop the reaction. After the samples were a
centrifuged at 12000 rpm at 4 C for 15 min, the super-
natants were filtered using centrifugal filter at 12000 rpm
at 4 C for 15 min, and the resulting filtrates (70 L)
were analyzed by ion exchange HPLC (TSK-GEL DEAE-
2SW, 4.6×250 mm; 5–35% 1 M HCO2NH4/20% MeCN,
20 min; 260 nm). The results are shown in Figure 2.
Biological Evaluations with Sea Urchin Egg
Homogenate or T -cells
These bioassays were carried out as reported previously
(Kudoh et al., 2005).
Biological Evaluations with Neuronal Cultured
Cells
NG108-15 neuroblastoma x glioma hybrid cells were
cultured as reported previously (Higashida et al., 1990).
Oregon Geen-loaded NG108-15 cells were incubated for
2 min in the following calcium-free medium (140 mM
K-glutamate, 20 mM PIPES, 5 mM EGTA, 2 mM
Mg-ATP, 10 mM glucose, 1 mM magnesium chloride,
0.01% bovine serum albumin, pH 6.8) at 37 C, and
subsequently permeabilized with 250 nM digitonin in
the calcium-free medium. cADPR (1–100 M), cADPcR
(1–100 M), or cADPcR (1–100 M) were applied
together with the digitonin-containing permeabilization
buffer to be allowed free passage of these nucleotides into
the cytoplasm. Concentrations of [Ca2+]i were determined
microspectrofluorometrically using fura-2 in differenti-
ated NG108-15 cells cultured on polylysine-coated glass
coverslips. The cells were loaded with fura-2 using
5 M Oregon Green 488 1,2-bis(2-aminophenoxy)ethane-
N ,N ,N ,N -tetraacetate acetoxymethylester (BAPTA-1
AM). Fluorescence was measured at 37 C with excitation
wavelengths of 485 nm and emission wavelengths of
538 nm using an Argus 50 Ca2+ microspectrofluoromet-
ric system (Hamamatsu Photonics, Hamamatsu, Japan)
and images were collected every 10 s for up to 5 min.
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The changes in fluorescence intensity of each cell were
expanded into an X-t plane, and data were performed
in fluorescence intensity at each time (x) divided by
resting intensity at time 0, i.e., Fx/F0 (Amina et al., 2010).
Data are expressed as mean± s.e.m. Statistical analysis
was performed using a Student’s t test. The criterion for
significance in all cases was p < 005.
Computational Calculations
For structure determination, molecular calculations were
carried out by AMBER11 (Case et al., 2010). cADPR
(1), cADPcR (2) and cADPtR (3) were modeled by the
General AMBER Force Field (Wang, et al., 2004). AM1-
BCC charge (Jakalian, A., Jack, D. B., and Bayly, C. I.
(2002). J. Comput. Chem. 23, 1623–1641) was used for
cADPR and its analogs assigned by Antechamber mod-
ule (Wang et al., 2006) of AMBER11. In the calculations,
interatomic distances restricts were determined by the
integrated volumes of the NOESY cross-peaks. As cross
peaks of cADPR and cADPcR, previously published data
were used (Kudoh, et al., 2005). For generating conforma-
tions, we carried out 400 ps simulated annealing molecu-
lar dynamics simulations: temperature was decreased from
1000 to 300 K. These simulations were repeated 100 times
with different initial velocity for each compound. In cal-
culated conformations, we chose and analyzed the lowest
energy conformation.
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